These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 17553552

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
    Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG.
    Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Factors responsible for "aspirin resistance" - can we identify them?
    Postuła M, Tarchalska-Kryńska B, Filipiak KJ, Kosior D, Serafin A, Huczek Z, Opolski G.
    Kardiol Pol; 2010 Apr; 68(4):403-11; discussion 412-3. PubMed ID: 20425699
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US.
    Circulation; 2007 Jun 26; 115(25):3156-64. PubMed ID: 17562955
    [Abstract] [Full Text] [Related]

  • 6. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
    Frelinger AL, Li Y, Linden MD, Barnard MR, Fox ML, Christie DJ, Furman MI, Michelson AD.
    Circulation; 2009 Dec 22; 120(25):2586-96. PubMed ID: 19996015
    [Abstract] [Full Text] [Related]

  • 7. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L, Rosiak M, Golanski J, Rysz J, Spychalska M, Watala C.
    Basic Clin Pharmacol Toxicol; 2006 May 22; 98(5):503-9. PubMed ID: 16635110
    [Abstract] [Full Text] [Related]

  • 8. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
    Malý J, Pecka M, Gregor J, Dulícek P, Blazek M, Malý R, Pudil R, Bláha M.
    Cas Lek Cesk; 2005 May 22; 144 Suppl 3():23-9. PubMed ID: 16335259
    [Abstract] [Full Text] [Related]

  • 9. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Lawrie AS, Purdy G, Machin SJ, Brown MM.
    Platelets; 2005 Aug 22; 16(5):269-80. PubMed ID: 16011977
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J, Jian Z, Huang L, Guo H, Huang J, Qian D, Fu W, Li A, Song Y.
    Biomed Pharmacother; 2009 Sep 22; 63(8):608-12. PubMed ID: 19019624
    [Abstract] [Full Text] [Related]

  • 14. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL.
    Dan Med J; 2012 Sep 22; 59(9):B4506. PubMed ID: 22951204
    [Abstract] [Full Text] [Related]

  • 15. Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin.
    Takahashi S, Ushida M, Komine R, Shimizu A, Uchida T, Ishihara H, Shibano T, Watanabe G, Ikeda Y, Murata M.
    Thromb Res; 2007 Sep 22; 119(4):517-24. PubMed ID: 16793119
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
    Homoncik M, Jilma B, Hergovich N, Stohlawetz P, Panzer S, Speiser W.
    Thromb Haemost; 2000 Feb 22; 83(2):316-21. PubMed ID: 10739392
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. PFA-100 system: a new method for assessment of platelet dysfunction.
    Mammen EF, Comp PC, Gosselin R, Greenberg C, Hoots WK, Kessler CM, Larkin EC, Liles D, Nugent DJ.
    Semin Thromb Hemost; 1998 Feb 22; 24(2):195-202. PubMed ID: 9579642
    [Abstract] [Full Text] [Related]

  • 20. A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease.
    Grove EL, Hvas AM, Johnsen HL, Hedegaard SS, Pedersen SB, Mortensen J, Kristensen SD.
    Thromb Haemost; 2010 Jun 22; 103(6):1245-53. PubMed ID: 20352155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.